320 related articles for article (PubMed ID: 30137438)
1. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/MS.
Thuzar M; Young K; Ahmed AH; Ward G; Wolley M; Guo Z; Gordon RD; McWhinney BC; Ungerer JP; Stowasser M
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31676899
[TBL] [Abstract][Full Text] [Related]
3. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
[TBL] [Abstract][Full Text] [Related]
4. Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism.
Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
Clin Chem; 2020 Mar; 66(3):483-492. PubMed ID: 32068832
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
[TBL] [Abstract][Full Text] [Related]
6. Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.
Juutilainen A; Savolainen K; Romppanen J; Turpeinen U; Hämäläinen E; Kemppainen J; Moilanen L; Pulkki K
Clin Chim Acta; 2014 Jun; 433():209-15. PubMed ID: 24661979
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of aldosterone LC-MS/MS-specific cutoffs for the saline infusion test.
Fries CM; Bae YJ; Rayes N; Sandner B; Isermann B; Stumvoll M; Fagotto V; Reincke M; Bidlingmaier M; Mandy V; Kratzsch J; Fenske WK
Eur J Endocrinol; 2020 Aug; 183(2):191-201. PubMed ID: 32460235
[TBL] [Abstract][Full Text] [Related]
8. Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS.
Fuss CT; Brohm K; Kurlbaum M; Hannemann A; Kendl S; Fassnacht M; Deutschbein T; Hahner S; Kroiss M
Eur J Endocrinol; 2021 Jan; 184(1):167-178. PubMed ID: 33112272
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism].
Song Y; He W; Yang S; Cheng Q; Hu J; Zhen Q; Long J; Feng Z; Li R; Wang Z; Ren W; Zhou B; Li Q
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):6-10. PubMed ID: 26796645
[TBL] [Abstract][Full Text] [Related]
10. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
[TBL] [Abstract][Full Text] [Related]
11. Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study.
Ahmed AH; Gordon RD; Ward G; Wolley M; Kogovsek C; Stowasser M
Clin Endocrinol (Oxf); 2015 Sep; 83(3):303-7. PubMed ID: 25523596
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism.
Stowasser M; Ahmed AH; Cowley D; Wolley M; Guo Z; McWhinney BC; Ungerer JP; Gordon RD
J Clin Endocrinol Metab; 2018 Nov; 103(11):4113-4124. PubMed ID: 30239841
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
Burrello J; Monticone S; Buffolo F; Lucchiari M; Tetti M; Rabbia F; Mengozzi G; Williams TA; Veglio F; Mulatero P
J Hypertens; 2016 May; 34(5):920-7. PubMed ID: 27031933
[TBL] [Abstract][Full Text] [Related]
14. Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism.
Nakai K; Tsurutani Y; Irie K; Teruyama K; Suematsu S; Matsui S; Makita K; Saito J; Omura M; Nishikawa T
Endocr J; 2024 May; 71(5):461-469. PubMed ID: 38417879
[TBL] [Abstract][Full Text] [Related]
15. Comparison between screening for primary aldosteronism with and without drug adjustment.
Hua Y; He Q
Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
[TBL] [Abstract][Full Text] [Related]
16. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
[TBL] [Abstract][Full Text] [Related]
17. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
18. Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.
Morimoto R; Ono Y; Tezuka Y; Kudo M; Yamamoto S; Arai T; Gomez-Sanchez CE; Sasano H; Ito S; Satoh F
Hypertension; 2017 Aug; 70(2):334-341. PubMed ID: 28652474
[TBL] [Abstract][Full Text] [Related]
19. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
20. Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.
Ahmed AH; Cowley D; Wolley M; Gordon RD; Xu S; Taylor PJ; Stowasser M
J Clin Endocrinol Metab; 2014 Aug; 99(8):2745-53. PubMed ID: 24762111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
